"Indinavir" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent and specific HIV protease inhibitor that appears to have good oral bioavailability.
Descriptor ID |
D019469
|
MeSH Number(s) |
D03.383.725.385
|
Concept/Terms |
L-735 524- L-735 524
- L 735 524
- L735 524
- L-735,524
- L 735,524
- L735,524
|
Below are MeSH descriptors whose meaning is more general than "Indinavir".
Below are MeSH descriptors whose meaning is more specific than "Indinavir".
This graph shows the total number of publications written about "Indinavir" by people in this website by year, and whether "Indinavir" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 1 | 0 | 1 |
2002 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Indinavir" by people in Profiles.
-
Yudkoff BL, Linsenmeyer TA, Oakley A, Kirshblum S. Urolithiasis associated with indinavir in a patient with spinal cord injury. J Spinal Cord Med. 2004; 27(3):263-5.
-
King NM, Melnick L, Prabu-Jeyabalan M, Nalivaika EA, Yang SS, Gao Y, Nie X, Zepp C, Heefner DL, Schiffer CA. Lack of synergy for inhibitors targeting a multi-drug-resistant HIV-1 protease. Protein Sci. 2002 Feb; 11(2):418-29.
-
Staszewski S, Morales-Ramirez J, Tashima KT, Rachlis A, Skiest D, Stanford J, Stryker R, Johnson P, Labriola DF, Farina D, Manion DJ, Ruiz NM. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. N Engl J Med. 1999 Dec 16; 341(25):1865-73.